How to choose chemotherapy in patients with lung cancer

In recent years, the incidence of lung cancer increased year after year, due to various reasons, patients with lung cancer at the time of diagnosis, there are different levels of transfer, lost opportunities surgery, some patients were Although surgery, but was soon in the lung or other sites have emerged metastatic lesions. So lung cancer chemotherapy as a systemic treatment methods, the importance of increasing attention. Patients with lung cancer chemotherapy should be how to choose? First, urgent measures for relief permanent solution, combining local body. Lung cancer patients to be under general conditions and different clinical symptoms of chemotherapy, severe dyspnea, or if the symptoms of massive hemoptysis, chemotherapy may be involved, choose bronchial artery or pulmonary artery catheterization treatment if a large number of the pleural effusion, thoracic drainage should be taken within the pleural local chemotherapy, but an improvement of symptoms when the disease has been confirmed or widespread or bone, brain, lung metastasis, be preferred systemic intravenous chemotherapy. Even if only a relatively limited tumor must also plus systemic chemotherapy, because distant metastasis of lung cancer is relatively common, and systemic chemotherapy to prevent tumor is an effective means of transfer. Second, the treatment must be standardized, and after cleaning essential. Many patients with lung cancer after chemotherapy has significantly narrowed mass, or even disappear, but it soon recurrence or metastasis, one of the important reasons is not standardized treatment. Lung cancer scales type adenovirus type and small cell undifferentiated type, which are not the types of cytology. Also different clinical stages, the drug programme, chemotherapy and have different treatment, must be given standardized treatment. Generally speaking, small-cell lung cancer because of the high degree of malignancy, as distant metastasis, it is necessary to maximize the use of the whole table clock chemotherapy treatment takes longer. Scales, adenocarcinoma consider local chemotherapy, some treatment can be shorter. As in lung cancer patients have not yet been found there may be a small metastases, as a precautionary measure, we should carry out "sweeping" systemic chemotherapy, in the destruction of residual cancer cells, as in the staging of the hand for more than Ⅱ, after the need for chemotherapy, in the time after 3-4 weeks suitable, methods, and treatment according to different cell types and stages them. Third, immune combination chemotherapy, biological missile good effect. Because chemotherapy drugs have greater toxicity, and some chemotherapy methods such as interventional treatment of a certain degree of trauma. That the use of chemotherapy subject to certain restrictions. And immunization and the method of combining chemotherapy, monoclonal antibodies and end all of the anti-cancer drug therapy has made up this shortfall, the cancer treatment significantly broaden the road. As a monoclonal antibody specific guidance, as it enters the body of the missile after direct tumor tissue, then connected with the drug or radioactive material after the separation and carrier-specific cancer cells killed off, and the right little damage normal tissue, can significantly enhance the effectiveness and reduce the side effects of chemotherapy
阿拉伯文到英语朝鲜语到英语德语到法语德语到英语俄语到英语法语到德语法语到英语荷兰语到英语葡萄牙语到英语日语到英语西班牙语到英语希腊语到英语意大利语到英语英语到阿拉伯文英语到朝鲜语英语到德语英语到俄语英语到法语英语到荷兰语英语到葡萄牙语英语到日语英语到西班牙语英语到希腊语英语到意大利语英语到中文(繁体)英语到中文(简体)中文到英语中文(繁体到简体)中文(简体到繁体)